Primary Recipient

UNIVERSITY OF CALIFORNIA, LOS ANGELES

Amount

$372,680.00

Award Date

5/21/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The tetraspan protein EMP2 is a novel biomarker for endometrial cancer prognosis and survival. Specificially, EMP2 expression is upregulated in a significant subset of endometrial hyperplasia and cancer patients. We therefore reasoned that EMP2 may be a